期刊文献+

异基因造血干细胞移植后急性移植物抗宿主病与肺损伤的关系 被引量:2

Association between acute graft versus host disease and lung injury after allogenic hematopoietic stem cell transplantation
原文传递
导出
摘要 目的分析研究异基因造血干细胞移植(allo—HSCT)后急性移植物抗宿主病(aGVHD)患者CT影像学特征和aGVHD诱导肺损伤的发病机制。方法对47例Ⅱ~Ⅳ度aGVHD患者进行胸部CT检查及aGVHD发生时血清干扰素γ(IFN—γ)和肿瘤坏死因子α(TNF-α)测定,4例抗aGVHD治疗后肺损伤疗效不佳患者进行肺组织活检,生存期〉6个月的患者定期肺功能和CT检查。结果47例患者在aGVHD后3d内CT显示20例异常,其中17例疑诊为aGVHD诱导肺损伤(5例弥漫性间质渗出、7例弥漫性间质和肺泡渗出、5例弥漫性间质和部分小叶肺泡渗出);此外,9例患者有双侧胸腔和心包积液,4例伴心肌肥厚。血清IFN-γ和TNF-α水平在有肺损伤和无肺损伤患者分别为:(6.9±1.8)μg/L、(400±102)μg/L和(6.34±1.2)μg/L、(428±83)μg/L,两者比较差异无统计学意义(均P〉0.05)。肺组织病理显示组织结构破坏、上皮细胞损伤、间质纤维化和以T细胞或巨噬细胞为主的浸润。aGVHD治疗与肺损伤治疗有效率呈正相关(r=0.771,P=0.01)。结论肺是aGVHD作用的靶器官之一,T细胞、巨噬细胞和IFN-γ、TNF—α与aGVHD造成肺损伤有关,aGVHD肺损伤可迁延为晚期非感染性肺损伤。 Objective To investigate the characteristics of chest high-resolution computed tomography (HRCT) and pathogenesis of acute graft versus host disease (aGVHD) -induced lung injury after allogenic hematopoietic stem ceil transplantation (allo-HSCT). Methods Chest HRCT was performed in 47 patients with aGVHD of grade Ⅱ - Ⅳ after allo-HSCT. Twenty-four of the patients underwent different treatment regimens against aGVHD. Before the treatment peripheral blood samples were collected to detect the serum interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α). Transbronchial biopsy was performed in 4 patients that failed to recover completely after treatment. Pulmonary function was examined in the patients who survived more than 6 months in every 3 months. Results Twenty of the 47 patients showed abnormal images by chest HRCT and 17 of the 20 patients were suspected to be with aGVHD-induced lung injury. The HRCT images were characterized by diffused interstitial infiltrate in 5 cases, diffused interstitial and alveolar infiltrate in 7 cases, and diffused interstitial and segmental lobar alveolar infiltrate in 5 cases. Nine cases had bilateral pleural effusion and hydropericardium, including 4 cases accompanied by myocardial hypertrophy. The levels of serum IFN-γ/and TNF-α of the patients with lung injury were (6. 9 ± 1.8 ) μg/L and(400 ± 102) μg/L respectively, both not significantly different from those of the patients without lung injury [ (6. 3 ± 1.2) μg/L and (428 ± 83 ) μg/L respectively, P = 0. 202, 0. 306 ]. The histopathology of the lung tissue was characterized by disorganization, epithelial cell damage, interstitial fibroplasias, and interstitial T lymphocyte or macrophage infiltrate. The effective rate of treatment for aGVHD-induced lung injury was positively correlated with that for aGVHD (r = 0. 771, P = 0. 01 ). Eleven of the 24 patients who survived more than 6 months had abnormal pulmonary function, including 7 out of the 9 patients with aGVHD-induced lung injury and 4 out the 15 patients without aGVHD-induced lung injury. There was no significant difference in the incidence of abnormal pulmonary function between the patients with and without lung injury (P= 0. 033). Conclusions Lung is one of the target organs of aGVHD. IFN-γ and TNF-α may play a role in the pathogenesis of aGVHD-induced lung injury. Acute GVHD-induced lung injury may progress to late-onset non-infectiouslunginjury.
出处 《中华医学杂志》 CAS CSCD 北大核心 2009年第8期538-542,共5页 National Medical Journal of China
基金 国家高技术研究发展计划(2006AA0224A0) 广东省自然科学基金(07005160)
关键词 造血干细胞移植 移植物抗宿主病 肺损伤 Hematopoietic stem cell transplantation Graft vs host disease Lung injury
作者简介 通信作者:刘启发,Email:liuqifa@fimmu.com
  • 相关文献

参考文献10

  • 1Yanik G, Cooke KR. The lung as a target organ of graft-versushost disease. Semin Hematol, 2006, 43: 42-52.
  • 2Cooke KR, Krenger W, Hill G, et al. Host Reactive Donor T cells are Associated with lung injury after experimental allogeneic bone marrow transplantation. Blood, 1998, 92 : 2571- 2580.
  • 3Yoshihara S, Yanik G, Cooke KR, et al. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia ( BOOP ), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 2007, 13 : 749-759.
  • 4Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation. Chest, 1996, 109 : 1066-1077.
  • 5FreudenbergerTD, Madtes DK, Curtis JR, et al. Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood, 2003, 102: 3822- 3828.
  • 6Beschomer WE, Saral R, Hutchins GM, et al. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. N Engl J Med, 1978, 299:1030-1036.
  • 7Clark JG, Hansen JA, Hertz MI, et al. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis, 1993, 147: 1601-1606.
  • 8Bolanos-MeadeJ, Ioffe O, Hey JC, et al. Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung. Am J Hematol, 2005, 79 : 132-135.
  • 9Afessa B, Litzow MR, Tefferi A. Bronehiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant, 2001, 28: 425 -434.
  • 10Ho VT, Weller E, Lee S J, et al. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 2001, 7 : 223 -229.

同被引文献23

  • 1叶丽萍,叶一秀,施兵,刘丽辉,金建刚,俞志勇,户江伟,陈虎.细胞因子在白血病异基因造血干细胞移植后移植物抗宿主病中的水平及其意义[J].放射免疫学杂志,2007,20(3):198-201. 被引量:3
  • 2Fukuda T, Hackman RC, outcomes of idiopathic Guthrie KA, et al. Risks and pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation[J]. Blood, 2003, 102(8): 2777 - 2785.
  • 3Soubani AO, Pandya CM. The spectrum of noninfectiouspulmonary complications following hematopoietic stem cell transplantation[J]. Hematol Oncol Stem Cell Ther, 2010, 3(3): 143 - 157.
  • 4Chen CI, Abraham R, Tsang R, et al. Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes[J]. Bone Marrow Transplant, 2001, 27(2): 177 - 182.
  • 5Uberti JP, Agovi MA, Tarima S, et al. Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia[J]. Bone Marrow Transplant, 2011, 46(1): 34 - 43.
  • 6Tomblyn MB, DeFor TE, MacMillan ML, et al. Impact of total body irradiation technique on interstitial pneumonitis and clinical outcomes of 623 patients undergoing hematopoietic cell transplantation for ALL: 25 years at the university of Minnesota[J]. Int J Radiat Oncol Biol Phys, 2007, 69(3): 575 - 581.
  • 7Oya N, Sasai K, Tachiiri S, et al. Influence of radiation dose rate and lung dose on interstitial pneumonitis after fractionated total body irradiation: acute parotitis may predict interstitial pneumonitis[J]. Int J Hematol, 2006, 83(1): 86 - 91.
  • 8Barrett A. Total body irradiation before bone marrow transplantation: a review[J]. Clin Radiol, 1982, 33(2): 131 - 135.
  • 9Keane T J, Van Dyk J, Rider WD. Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation[J]. Int J Radiat Oncol Biol Phys, 1981, 7(10): 1365 - 1370.
  • 10Ruiz-Camps I, Len O, de la Cfimara R, et al. Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients[J]. Antivir Ther, 2011, 16(7): 951 - 957.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部